Evidence map›Paper›PMID 35471668›Full record

ArticleWorld journal of urology2022

Incidence of venous thromboembolism in benign urologic reconstructive cases.

Nathan M Shaw, Nizar Hakam, Jason L Lui, Behnam Nabavizadeh, Kevin D Li, Patrick Low, Behzad Abbasi, Benjamin N Breyer

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nathan M ShawDepartment of Urology, University of California San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA.ORCID http://orcid.org/0000-0002-5710-9299
Nizar HakamDepartment of Urology, University of California San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA.
Jason L LuiDepartment of Urology, University of California San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA.
Behnam NabavizadehDepartment of Urology, University of California San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA.
Kevin D LiDepartment of Urology, University of California San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA.
Patrick LowDepartment of Urology, University of California San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA.
Behzad AbbasiDepartment of Urology, University of California San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA.
Benjamin N BreyerDepartment of Urology, University of California San Francisco, 1001 Potrero Suite 3A, San Francisco, CA, 94110, USA. Benjamin.Breyer@ucsf.edu.
University of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the rate of perioperative venous thromboembolism (VTE) among patients undergoing common benign urologic reconstructive cases. We hypothesize that this rate will be lower than previously described.

methodsWe utilized the American College of Surgeons National Surgical Quality Improvement Project database from 2015 to 2019 to evaluate 30-day perioperative risk of VTE. Patients ≥ 18 years old undergoing benign urologic reconstructive cases were selected using Current Procedural Terminology (CPT) codes. Demographic, comorbidity, and operative variables were captured. The primary outcome was VTE within the 30-day postoperative period.

resultsWe identified 8467 patients who met inclusion criteria. The majority of patients were male (> 95%) with an average age of 65 and BMI of 29.6. There were 23 VTE events (0.27%) within the 30-day perioperative period. Fourteen (14/59) procedures had a perioperative VTE. Many of the traditional factors for VTE including operative time and obesity significantly increased risk of VTE in univariate analysis. In multivariate analysis, only BMI (OR 1.09; 95% CI 1.01-1.12) and inpatient status (OR 4.42; 95% CI 1.9-10.2) were correlated with increased perioperative VTE.

conclusionThe rate of VTE among patients undergoing benign urologic reconstructive cases is low. Providers should continue to have high index of suspicion particularly for inpatients with high BMI in addition to other known risk factors for VTE.

Indexed as

Plastic Surgery ProceduresVenous ThromboembolismAdolescentAgedFemaleHumansIncidenceMaleOperative TimePostoperative ComplicationsRisk FactorsACS-NSQIPDeep vein thrombosis (DVT)Pulmonary embolismReconstructive urologyVenous thromboembolism (VTE)

Identifiers

PMID35471668
OpenAlexW4224451685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.